Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue.

Kathryn C. Fitzgerald,Bridget Morris,Aurash Soroosh,Alexandra Balshi,Dermot Maher,Adam I. Kaplin,Bardia Nourbakhsh

Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue.

2020

Kathryn C. Fitzgerald
Bridget Morris
Aurash Soroosh
Alexandra Balshi
Dermot Maher
Adam I. Kaplin
Bardia Nourbakhsh

Background:Fatigue is the most common symptom of MS and has no effective pharmacotherapy.Objective:To determine the tolerability, safety, and efficacy of low-dose ketamine infusion for MS-related f...

Keywords:

Ketamine
Midazolam
Medicine
Anesthesia
Active placebo
Tolerability
Multiple sclerosis
low dose
Physical therapy
Randomized controlled trial

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations